Juvenescence Ltd - Mar 14, 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Director, 10%+ Owner
Signature
/s/ Gregory Bailey, Executive Chairman of Juvenescence Ltd.
Stock symbol
AGE
Transactions as of
Mar 14, 2023
Transactions value $
$0
Form type
4
Date filed
3/22/2023, 04:20 PM
Previous filing
Feb 17, 2023
Next filing
May 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGE Common Stock Gift $0 -16.4M -100% $0.00* 0 Mar 14, 2023 Direct F1
holding AGE Common Stock 16.4M Mar 14, 2023 By Juvenescence US Corp. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a transfer of securities to the reporting person's wholly owned subsidiary, Juvenescence US Corp.

Remarks:

Director by deputization